Cancer drug helped delay progression of Duchenne muscular dystrophy in
July 4, 2022
Researchers at UBC’s School of Biomedical Engineering have discovered that an existing cancer drug could have potential as a treatment for muscular dystrophy. Duchenne muscular dystrophy (DMD) is a severe genetic disorder that leads to progressive muscle weakness. Image Credit: University of British Columbia The researchers found that the drug — …
